NOVATO, Calif., Nov 5 /PRNewswire/ -- Diamics, Inc., a privately-held company developing products for cervical cancer screening and diagnostics, today announced that it has added Paul Blumenthal, MD, MPH, Professor, Department of Obstetrics & Gynecology, Stanford University, School of Medicine and Tom Cox, MD, Director of Gynecology & Colposcopy, University of California, Santa Barbara and Executive Medical Director of the National HPV and Cervical Cancer Prevention Resource Center to the company’s Medical Advisory Board.
“We are delighted to welcome both Dr. Blumenthal and Dr. Cox to Diamics’ Medical Advisory Board,” said Peter Gombrich, CEO, Diamics. “The company will clearly benefit from their experience in the diagnosis of cervical cancer as we move forward with marketing our Pap-Map System for cervical cancer screening and our automated, molecular diagnostic-based C-Map system for point of care use.”
Dr. Blumenthal completed his internship and residency at Michael Reese Hospital and Medical Center in Chicago and did a fellowship at University of California, Los Angeles Health Sciences. He is Board Certified by the American Board of Obstetrics and Gynecology. He has received multiple awards for his professional and academic achievements including the 2007 Michael Burnhill Award given by the Association of Reproductive Health Professionals.
Dr. Tom Cox received his MD from the Baylor College of Medicine and completed his residency in obstetrics and gynecology at Kaiser Permanente Hospital in San Francisco. He went on to practice OB/GYN in Marin County, California and since 1986 has been a professor at University of California, Santa Barbara. His main interest is in colposcopy and lower genital tract disease. Dr. Cox published two of the earliest studies on the clinical utility of testing for HPV. He has served on the American College Health Association’s Task Force on HPV for ten years and on the Oncology Section of the National Medical Board of Planned Parenthood since 1997. Dr. Cox is Associate Editor of the Journal of Lower Genital Tract Disease, and has published five textbook chapters and numerous articles on the subject of HPV and Pap management.
Drs. Blumenthal and Cox join other members of the Diamics’ Medical Advisory Board: Stephen Bearg, MD, OB/GYN and Managing Partner, Women’s Medical Associates, Juan Felix, MD, Director, Surgical Pathology and OB/GYN Pathology, University of Southern California Medical Center, Eileen B. King, MD, Clinical Professor of Pathology & Research Pathologist, University of California, San Francisco (Retired) and Ralph M. Richard, MD, Professor of Pathology in Obstetrics & Gynecology; Vice-Chair, Department of Pathology, Columbia College of Physicians & Surgeons and Sloane Hospital.
About Diamics, Inc.
Diamics, Inc. is a privately owned medical device and diagnostics company. The developing, manufacturing, and marketing cost effective, molecular-based cancer screening and diagnostic systems that will increase long-term cancer survival rates through early detection. Diamics’ management team has an extensive track record of success in the medical device and diagnostics industries. The company’s mission is twofold: to help medical personnel worldwide improve the lives of the people they treat and to generate a return on investment for its shareholders. For more information, please visit: http://www.diamics.com.
pgombrich@diamics.comjlarson@labfive.com
CONTACT: Peter Gombrich of Diamics, +1-415-883-0414,
pgombrich@diamics.com; or Jennifer Larson, +1-415-409-2729,
jlarson@labfive.com, for Diamics
Web site: http://www.diamics.com/
